Spindle-shaped CD163+ rosetting macrophages replace CD4 + T-cells in HIV-related classical Hodgkin lymphoma

Modern Pathology

Volumn 26, Issue 5, 2013, Pages 648-657

  Hartmann, Sylvia ^a   Jakobus, Christina ^a   Rengstl, Benjamin ^a   Döring, Claudia ^a   Newrzela, Sebastian ^a   Brodt, Hans Reinhard ^a   Wolf, Timo ^a   Hansmann, Martin Leo ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

HIV; Hodgkin lymphoma; macrophages

Indexed keywords

CD163 ANTIGEN; CD4 ANTIGEN;

ADULT; AGED; ARTICLE; CLASSICAL HODGKIN LYMPHOMA; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIOID CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; REED STERNBERG CELL; ROSETTE FORMATION; SARCOMATOID CARCINOMA; SPINDLE CELL; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; FEMALE; HIV INFECTIONS; HIV-1; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; REED-STERNBERG CELLS;

EID: 84877071515     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.217     Document Type: Article

References (42)

1. Yotsumoto M, Hagiwara S, Ajisawa A, et al. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan. Int J Hematol 2012;96:247-253.
2. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006;108:3786-3791.
3. Clifford GM, Rickenbach M, Lise M, et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 2009;113:5737-5742.
4. Bohlius J, Schmidlin K, Boue F, et al. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4(\+) T-cell lymphocytes. Blood 2011;117:6100-6108.
5. Marshall NA, Christie LE, Munro LR, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004;103:1755-1762.
6. Bosch Princep R, Lejeune M, Salvado Usach MT, et al. Decreased number of granzyme B\+ activated CD8\+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma. Ann Hematol 2005;84:661-666.
7. Thompson LD, Fisher SI, Chu WS, et al. HIVassociated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Pathol 2004;121:727-738.
8. Pelstring RJ, Zellmer RB, Sulak LE, et al. Hodgkin's disease in association with human immunodeficiency virus infection. Pathologic and immunologic features. Cancer 1991;67:1865-1873.
9. Kiyasu J, Aoki R, Tanaka PY, et al. FOXP3(\+) regulatory and TIA-1(\+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma. Pathol Int 2012;62:77-83.
10. Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362:875-885.
11. Kamper P, Bendix K, Hamilton-Dutoit S, et al. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica 2011;96: 269-276.
12. Tzankov A, Matter MS, Dirnhofer S. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Pathobiology 2010;77:301-308.
13. Azambuja D, Natkunam Y, Biasoli I, et al. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. Ann Oncol 2012;23:736-742.
14. Harris JA, Jain S, Ren Q, et al. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma. Diagn Pathol 2012;7:12.
15. Renné C, Willenbrock K, Kü ppers R, et al. Autocrineand paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood 2005;105: 4051-4059.
16. Ma Y, Visser L, Roelofsen H, et al. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 2008;111:2339-2346.
17. Imai T, Baba M, Nishimura M, et al. The Tcell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997;272:15036-15042.
18. Goodenow MM, Rose SL, Tuttle DL, et al. HIV-1 fitness and macrophages. J Leukoc Biol 2003;74: 657-666.
19. Flavell DJ, Wright DH. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes. Br J Cancer 1989;59:165-173.
20. Hansch HC, Smith DA, Mielke ME, et al. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4\+ T cells. Int Immunol 1996;8:1299-1310.
21. Muller H, Takeshita M. In situ immunophenotype of macrophages and lymphocytes in granuloma formation of tuberculous lymphadenitis in HIV-infected and immunocompetent patients. Res Virol 1991;142: 159-172.
22. Muller-Hermelink HK, Kaiserling E, Sonntag HG. Modulation of epithelioid cell granuloma formation to apathogenic mycobacteria by cyclosporin A. Pathol Res Pract 1982;175:80-96.
23. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-555.
24. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141: 39-51.
25. Crouser ED, Culver DA, Knox KS, et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med 2009;179: 929-938.
26. Ehrt S, Schnappinger D, Bekiranov S, et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-and phagocyte oxidase. J Exp Med 2001;194: 1123-1140.
27. Mantovani A, Allavena P, Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 2004;40:1660-1667.
28. Lugo-Villarino G, Verollet C, Maridonneau-Parini I, et al. Macrophage polarization: convergence point targeted by Mycobacterium tuberculosis and HIV. Front Immunol 2011;2:43.
29. Brown JN, Kohler JJ, Coberley CR, et al. HIV-1 activates macrophages independent of Toll-like receptors. PLoS One 2008;3:e3664.
30. Fischer-Smith T, Tedaldi EM, Rappaport J. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res Hum Retroviruses 2008;24:417-421.
31. Burdo TH, Lentz MR, Autissier P, et al. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis 2011;204: 154-163.
32. Fuentes-Duculan J, Suarez-Farinas M, Zaba LC, et al. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 2010;130:2412-2422.
33. Cassol E, Cassetta L, Rizzi C, et al. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol 2009;182:6237-6246.
34. Chen X, Ye J. Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock. Microbiol Immunol 2011;55:736-742.
35. Hiscott J, Nguyen TL, Arguello M, et al. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 2006;25: 6844-6867.
36. Haller O, Kochs G, Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 2007;18:425-433.
37. Audouin J, Diebold J, Pallesen G. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 1992;167:381-384.
38. Guidoboni M, Ponzoni M, Caggiari L, et al. Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma. J Virol 2005;79: 2643-2649.
39. Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 1999;23:1233-1240.
40. Kanzler H, Kü ppers R, Helmes S, et al. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000;95:1023-1031.
41. Mao Z, Quintanilla-Martinez L, Raffeld M, et al. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 2007;31:1605-1614.
42. Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007;13: 5124-5132.